Skip to content
10-Q

Quarterly Report

Apotheca Biosciences, Inc.

0001079974-18-000540

← back to feed
Filed
Oct 2, 2018 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2019 · Oct 1, 2018 113.91M sh
Operating Cash Flow Q2 2019 · Jul 31, 2018 $0
Cash And Equivalents Q2 2019 · Jul 31, 2018 $0
Cash And Equivalents Q2 2019 · Jan 31, 2018 $0
Stockholders Equity Q2 2019 · Jul 31, 2018 −$2.51M
Stockholders Equity Q2 2019 · Feb 25, 2018 $199.91K
Stockholders Equity Q2 2019 · Jan 31, 2018 −$222.25K
Current Liabilities Q2 2019 · Jul 31, 2018 $2.02M
Current Liabilities Q2 2019 · Jan 31, 2018 $222.25K
Total Liabilities Q2 2019 · Jul 31, 2018 $2.02M
Total Liabilities Q2 2019 · Jan 31, 2018 $222.25K
Total Assets Q2 2019 · Jul 31, 2018 $0
Total Assets Q2 2019 · Jan 31, 2018 $0
Sga Expense Q2 2019 · Jul 31, 2018 $10.05K
Sga Expense Q2 2019 · Jul 31, 2018 $26.42K
Net Income Q2 2019 · Jul 31, 2018 −$2M
Net Income Q2 2019 · Jul 31, 2018 −$2.22M
Operating Income Q2 2019 · Jul 31, 2018 −$10.05K
Operating Income Q2 2019 · Jul 31, 2018 −$26.42K
Operating Income Q2 2019 · Jul 31, 2017 −$18.85K
Operating Income Q2 2019 · Jul 31, 2017 −$23.17K
Revenue Q2 2019 · Jul 31, 2018 $0
Revenue Q2 2019 · Jul 31, 2018 $0
Revenue Q2 2019 · Jul 31, 2017 $0
Revenue Q2 2019 · Jul 31, 2017 $0